Pure tone audiometric findings in HIV positive adults in university of Port Harcourt teaching hospital

Authors

  • Ibekwe Matilda Uju ENT Surgery Department, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
  • Alasia Datonye Dennis Department of internal Medicine, University of Port Harcourt, Port Harcourt, Nigeria.

DOI:

https://doi.org/10.18203/2320-6012.ijrms20210866

Keywords:

Hearing impairment, Human immunodeficiency virus, CD4 count, Antiretroviral therapy

Abstract

Background: It is known that HIV infection is a risk factor for hearing loss. Therefore this study is to determine the pattern and severity of hearing loss and whether there is a correlation between the CD4 count and hearing impairment in the HIV positive adult patients seen in the infectious outpatient clinic of university of Port Harcourt teaching hospital (UPTH).

Methods: A hospital based descriptive cross sectional study of consecutive patients that are HIV positive seen in the infectious outpatient clinic of UPTH within a period of three months, from May to July of 2020. The biodata, history of hearing difficulties and management of the disease was obtained using a semi structured questionnaire. All the patients had otoscopy done and hearing assessment with pure tone audiometry (PTA). The analysis was done with the SPSS version 25 software at a 95% confidence interval and a p value less than 0.05 was considered significant.

Results: The study involved 234 subjects comprising 127 males and 107 females. Hearing impairment was seen in n=113 (48.29%). The patients with CD4 count less than 500 cells/mm2 was found to have more hearing loss; 55.8% than those with counts greater than 500 cells/mm2. Age distribution was statistically significant with a p=0.0001.

Conclusions:  The pure tone audiometric pattern in the majority of the studied population was more of CHL. The age, duration of ARVT and the CD4 count all had statistically significant association with hearing loss in the HIV positive adults.

 

References

United States Embassy in Nigeria. Nigeria HIV Fact Sheet. 2011. Http://Photos.state.gov/libraries/ nigeria/231771/Public/Decemberhivfactsheet. Last accessed on 20 December 2020.

Nakku D, Nyaiteera V, Llowet E, Nanserra D, Nakalema G, Westerg B et al. HIV status and hearing loss among children between 6 and 12 years of age at a large urban health facility in South Western Uganda. Int J Pediatr Otorhinolaryngol. 2017;101:172-7.

Zuniga J. Communication Disorders and HIV disease. J Int Assoc Physicians AIDS Care. 1999;5(4):16-23.

Van der Westhuizen Y, Swanepoel de W, Heinze B, Hofmeyr LM. Auditory and ontological manifestations in adults with HIV/AIDS. Int J Audiol. 2013;52(1):37-43.

Chao C, Czechowicz JA, Messner AH. High prevalence of hearing impairment in HIV-infected Peruvian children. Otolaryngol Head Neck Sur. 2012;146:259-65.

Schouten JT, Lockhart DW, Rees TS, Collier AC, Marra CM. A prospective study of hearing changes after beginning zidovudine or diagnosing in HIV -1 treatment – naive people. BMC Infect Dis. 2006;6:28.

Bankaitis evoked potentials. Seminars in Hearing. 1998;19:177-83.

Pagano MA, Cahn PE, Garau MD, Carlos A, Mangone MD, Hector A et al. Brainstem evoked potentials in human immunodeficiency virus- seropositive patients with and without acquired immunodefiency syndrome. Arch Neurol. 1992;49(2):166-9.

Weber R, Pinheiro Neto CD, Miziara ID, Araujo Filho BC: HAART impact on prevalence of chronic otitis media in Brazilian HIV infected children. Braz J Otorhinolaryngol. 2006;72:509-14.

Molyneux EM, Tempo M, Kayira K, Bwanaisa L, Mweneychanya J, Njobvu H. The effect of HIV infection on paediatric bacterial meningitis in Blantyre Malawi. Arch Dis children. 2003;88(12):1112-8.

Battegay M, Nuesch R, Hirschal B,Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancent Infectious Diseases. 2006;6(5):280-7.

Pathai S, Lawn SD, Weiss HA, Cook C, Bekker LG, Gilbert CE et al. Increased ocular lens density in HIV- infected individuals with low nadir CD4 counts in South Africa: evidence of accelerated aging. J Acquir Immune Defic Syndr. 2013;63(3):307-14.

Centers for Disease Control and Prevention. Revised Surveillance case definition for HIV infection- United States. 2014. MMWR Recomm Rep. 2014;63(rr-03):1-10.

Mata Castro N, Yebra Bango M, Tutor de Ureta P, Villarreal Garcia-Lomas M, Garcia Lopez F. Hearing loss and human immunodeficiency virus infection: study of 30 patients. Rev Clin Esp. 2000;200(5):271-4.

Reyes-Contreras L, Silva –Rojas A, Ysunza-Rivera A, Jimenez-Ruiz G, Berruecos-Villalobos P, Romo-Gutierrez G. Brainstem auditory evoked response in HIV-infectyed patients with and without AIDS. Arch Med Res. 2002;33(1):25-8.

Matas CG, Angrisani RG, Magliero FCL, Segrado AAC. Audiological manifestations in HIV positive adults. Clinics. 2014;69(7):469-75.

Sauvaget E, Kici S, Petelle B, Kania R, Chabriat H, Tran Huy P. Vertebrobasilar occlusive Disorders presenting as sudden sensorineural hearing loss. Laryngoscope. 2004;114(2):327-32.

Roland Jr JT, Alexiades G, Jackman AH, Hillman D, Shapiro W. Cochlear impantation in human immunodeficiency virus infected patients. Otol and Neurotol. 2003;24(6):892-5.

Campanini A, Marani M, Mastroianni A, Cancellieri C, Vicini C. Human Immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies. Acta Otorhinolaryngol Ital. 2005;25(1):30-5.

Simdom J, Wlters D, Bartlett S, Connick E. Ototoicity associated with use of nucleoside analog reverse transcriptase inhibitors: a report of 3 possible cases and review of the literature. Clin Infect Dis. 2001;34(3):2100-2.

Vieira ABC, Greco DB, Teofilo MMM, Goncalves DU. Manifestacoes Otoneuroloicas associadas e’ terapia anti-retroviral. Rev Soc Med Trop. 2008;41(1):65-9.

Fasunla AJ, Ogunkeyede SA, Afolabi SO. Hearing loss among adolescents on Antiretroviral Therapy: A need for periodic hearing assessment. Ann Ibd Pg Med. 2019;17(1):14-8.

Bengono G, Binam F, Ndjolo A, Essame Oyono J, Fouda Onana A, Djeugabeng F. La pathologie ORL et L’infection au VIH a’ Yaounde. Bull Liais Doc OCEAC. 1999;32(3):15-9.

Khoza k, Ross E. Auditory function in a group of adults infected with HIV/AIDS in an out -patient clinic in Gauteng, South Africa. The South African Journal of Communication Disorders. 2002;49:17-27.

Matas CG, Santos Filha VA, Juan KR, Pinto FR, Goncalves IC. Audiological manifestations in children and adults with AIDS. Pro Fono 2010;22:269-74.

Somefun A, Nwawolo CC, Okeowo PA, Ogban LU, Akanmu AS, Okanny CC et al. Otorhinolaryngological manifestations of HIV/AIDS in Lagos. Niger Postgrad Med J. 2001;8(4):170-4.

Torre P, Hoffman H, Springer G, Cox C, Young MA, Margolick JB et al. Hearing loss among HIV- seropositive and HIV –seronegative men and women. JAMA Otolaryngol Head Neck Surg. 2015;141(3):202-10.

Luque AE, Orlando MS, Leong UC, Allen PD, Guido JJ, Yang H et al. Hearing function in patients living with HIV/AIDS. Ear Hear. 2014;35:282-90.

Hasse B, Ledergerber B, Furrer H, Battlegay M, Hirschel B, Cavassini M et al. Morbidity and aging in HIV- infected persons: the Swiss HIV Cohort Study. Clin Infect Dis. 2011;53(11):1130-139.

Khoza-Shangase K. HIV/AIDS and auditory function in adults: the need for intensified research in the developing world. Afr J AIDS Res. 2010;9(1):1-9.

Alabi BS, Salami KA, Afolabi A, Dunmade D, Aremu KS, Olawunmi O et al. Otolaryngologic manifestations among HIV/AIDS patients in a Nigerian tertiary health institution: an update. Arquivos Int. Otorrinolaringol(Impr). 2010;14(4):398-403.

Khoza –Shangase K. An analysis of auditory manifestations in a group of adults with AIDS prior to antiretroviral therapy. Afr J Infect Dis. 2011;5(1):11-22.

Downloads

Published

2021-02-25

How to Cite

Uju, I. M., & Dennis, A. D. (2021). Pure tone audiometric findings in HIV positive adults in university of Port Harcourt teaching hospital. International Journal of Research in Medical Sciences, 9(3), 685–690. https://doi.org/10.18203/2320-6012.ijrms20210866

Issue

Section

Original Research Articles